Natural history and clearance of HPV after treatment of precancerous cervical lesions

Histopathology

Volumn 52, Issue 3, 2008, Pages 381-386

  Aerssens, A ^a   Claeys, P ^a,c   Garcia, A ^b   Sturtewagen, Y ^c   Velasquez, R ^b   Vanden Broeck, D ^a   Vansteelandt, S ^a   Temmerman, M ^a,c   Cuvelier, C A ^c  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE NICARAGUA   (Nicaragua)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Clearance; Human papillomavirus; Precancerous cervical lesion

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; COLPOSCOPY; CRYOTHERAPY; CYTOLOGY; DNA SCREENING; ELECTROSURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT CARE; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CRYOSURGERY; DNA, VIRAL; ELECTROSURGERY; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 38849169705     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02956.x     Document Type: Article

References (22)

1. Ferlay JFB, Pisaniand P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5, version 20. Lyon : IARC Press, 2004.
2. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005 6 204.
3. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999 189 12 19.
4. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 1998 338 423 428.
5. Bishop A, Sherris J, Tsu VD, Kilbourne-Brook M. Cervical dysplasia treatment: key issues for developing countries. Bull. Pan Am. Health Organ. 1996 30 378 386.
6. Mitchell MF, Tortolero-Luna G, Cook E, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet. Gynecol. 1998 92 737 744.
7. Rodriguez AC, Burk R, Herrero R et al. The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sex. Transm. Dis. 2007 34 494 502.
8. Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol. 2006 14 40470.
9. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 2007 7 11 22.
10. Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet. Gynecol. 2002 100 965 971.
11. Murta EF, Conti R, Rodovalho J, Barcelos AC, Adad SJ, de Souza H. Outcome after treatment of high-grade squamous intraepithelial lesions: relation between colposcopically directed biopsy, conization and cervical loop excision. Eur. J. Gynaecol. Oncol. 2004 25 587 590.
12. Natee J, Therasakvichaya S, Boriboonhirunsarn D. Prevalence and risk factors for residual cervical neoplasia in subsequent hysterectomy following LEEP or conization. J. Med. Assoc. Thai. 2005 88 1344 1348.
13. Bollen LJ, Tjong AHSP, van der Velden J et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol. Oncol. 1999 72 199 201.
14. Nobbenhuis MA, Meijer CJ, van den Brule AJ et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br. J. Cancer 2001 84 796 801.
15. Cuschieri KS, Cubie HA, Whitley MW et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J. Clin. Pathol. 2005 58 946 950.
16. Ho GY, Burk RD, Klein S et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 1995 87 1365 1371.
17. Bulkmans NW, Berkhof J, Bulk S et al. High-risk HPV type-specific clearance rates in cervical screening. Br. J. Cancer 2007 96 1419 1424.
18. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 2007 195 1582 1589.
19. Saw HS, Lee JK, Lee HL, Jee HJ, Hyun JJ. Natural history of low-grade squamous intraepithelial lesion. J. Low. Genit. Tract. Dis. 2001 5 153 158.
20. Hindryckx P, Garcia A, Claeys P et al. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix. Sex. Transm. Infect. 2006 82 334 336.
21. Chua KL, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol. Oncol. 1997 66 108 113.
22. Nuovo G, Moritz J, Kowalik A, Chalas E, Kaplan B, Mann W. Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization. Gynecol. Oncol. 1992 46 304 308.